- Home
- COF vs BDX Comparison
COF vs BDX Comparison
Compare COF & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | COF | BDX |
|---|---|---|
| Founded | 1988 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.8B | 51.5B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | COF | BDX |
|---|---|---|
| Price | $177.49 | $159.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 11 |
| Target Price | ★ $269.31 | $189.60 |
| AVG Volume (30 Days) | ★ 5.0M | 2.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 1.76% | ★ 2.57% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.34 |
| Revenue | N/A | ★ $21,840,000,000.00 |
| Revenue This Year | $96.05 | N/A |
| Revenue Next Year | $4.97 | $2.53 |
| P/E Ratio | ★ $52.03 | $122.22 |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $143.22 | $160.89 |
| 52 Week High | $259.64 | $231.82 |
Technical Indicators
Market Signals| Indicator | COF | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 27.50 | 23.22 |
| Support Level | N/A | N/A |
| Resistance Level | $226.76 | $195.22 |
| Average True Range (ATR) | 6.82 | 4.23 |
| MACD | -1.12 | -1.10 |
| Stochastic Oscillator | 3.29 | 4.32 |
Price Performance
Historical ComparisonAbout COF Capital One Financial Corporation
Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending. Following the acquisition of Discover in 2025, the firm also has a modest personal loan business, though credit card lending provides the majority of the bank's revenue.
About BDX Becton Dickinson and Company
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.